z-logo
open-access-imgOpen Access
Pattern of glomerular diseases in oman: A study based on light microscopy and immunofluorescence
Author(s) -
Nasar Alwahaibi,
Taiseer Ahmed Alhabsi,
Samira Abdullah Alrawahi
Publication year - 2013
Publication title -
saudi journal of kidney diseases and transplantation/našrat amraḍ wa zira'aẗ al-kulaẗ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 30
eISSN - 2320-3838
pISSN - 1319-2442
DOI - 10.4103/1319-2442.109616
Subject(s) - medicine , lupus nephritis , pathology , renal biopsy , glomerulopathy , focal segmental glomerulosclerosis , membranous nephropathy , minimal change disease , biopsy , nephropathy , immunofluorescence , glomerulonephritis , kidney , disease , immunology , antibody , diabetes mellitus , endocrinology
Light microscopy and immunofluorescence play an important part in the final diagnosis of renal biopsy. The aim of this study was to analyze the pattern of various glomerular diseases in Oman. A total of 424 renal biopsies were retrospectively analyzed at the Sultan Qaboos University Hospital between 1999 and 2010. Focal and segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous glomerulopathy (MGN) and IgA nephropathy were the most common primary glomerular diseases encountered, accounting for 21.2%, 17%, 12.3% and 8.3%, respectively, of all cases. Lupus nephritis was the most common secondary glomerular disease and was the most prevalent among all biopsies, accounting for 30.4% of all biopsies. Amyloidosis was seen in only two cases. The presence of fluorescein isothiocyanatefibrin in all renal cases was low when compared with IgG, IgA, IgM, C3 and C1q markers. In conclusion, based on the findings of this study, lupus nephritis was the most common of all glomerular diseases and FSGS was the most common primary glomerular disease. The importance of fluorescein isothiocyanate-fibrin in the diagnosis of renal biopsy needs to be further investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here